Citigroup Downgrades Lincare Holdings To Hold, Lowers PT To $21

Citigroup has downgraded Lincare Holdings LNCR from Buy to Hold and has lowered the price target from $26 to $21.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesPrice TargetAnalyst RatingsCitigroupHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!